As previously announced, the CADTH pan-Canadian Oncology Drug Review (pCODR) program is recruiting new members for the pCODR Expert Review ...
CADTH has undertaken an update of the Guidance Document for the Costing Process. This document is intended to help researchers determine ...
NICE has today published draft guidance on adalimumab (Humira, AbbVie), etanercept (Enbrel, Pfizer), infliximab (Remicade, Merck Sharp & Dohme; Inflectra, ...
Aprecia Pharmaceuticals announced today that the U.S. Food and Drug Administration (FDA) has accepted for filing the company’s New Drug ...
A NSW leukaemia patient has told of his family's distress trying to raise $16,000 every three weeks for each dose ...
CADTH is pleased to invite all interested parties to provide feedback on the list of included studies being considered for ...
AbbVie filed a New Drug Submission (NDS) to Health Canada seeking approval for the company's investigational, all-oral, interferon-free regimen for the ...
Genzyme, a sanofi company, announced today that the Yukon Pharmaceutical Programs have included Aubagio (teriflunomide) 14 mg on the territorial drug ...
A furious political row is set to erupt this week over a key part of David Cameron’s health service strategy. ...
AbbVie receives Health Canada approval for Holkira Pak (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the ...
Below a list of forthcoming submissions that have recently been added to the SMC's programme. Information in relation to the drug ...
Genzyme, a Sanofi company, announced today that Québec's Institut national d'excellence en santé et services sociaux (INESSS) has recommended that Lemtrada (alemtuzumab) 12 ...